An evidence-aware, side-by-side comparison for U.S. shoppers — updated June 12, 2026.
Wegovy and JellyLean are not the same kind of product, and we won't pretend they are. Wegovy (semaglutide) is an FDA-approved prescription GLP-1 receptor agonist injection from Novo Nordisk, indicated for chronic weight management in adults with obesity or overweight with a weight-related condition, alongside diet and exercise. It is a medication — not a supplement — with clinically demonstrated weight loss, prescription-only access, and pharmaceutical pricing: list price is $1,349.02 per package, with NovoCare® self-pay options from $199–$349 per month depending on dose and current offers, and insured patients potentially paying $0–$25 per month. JellyLean, by contrast, is a $49 over-the-counter natural gummy that supports the body's own GLP-1 & GIP pathways — gradual, supplement-level support with no prescription required and a 60-day money-back guarantee. This page compares them honestly on cost, access, results, and safety so you can decide which route fits your situation.
| Criteria | JellyLean™ | Wegovy |
|---|---|---|
| Category | Dietary supplement (OTC) | FDA-approved prescription medication |
| Format | Daily gummy | Once-weekly injection pen (oral pill version also exists) |
| Core approach | Supports the body's own GLP-1 & GIP pathways | Pharmaceutical GLP-1 receptor agonist (semaglutide) |
| Formulation | Apple cider vinegar–based natural formula | Semaglutide — FDA-approved GLP-1 receptor agonist for chronic weight management |
| Access | Over the counter — no prescription | Prescription only — pharmacy or NovoCare® Pharmacy home delivery |
| Guarantee | 60-day money-back guarantee | No money-back guarantee (prescription medication) |
| Price | From $49/bottle (bundles lower per-bottle cost) | List price $1,349.02/package; NovoCare self-pay from $199–$349/month depending on dose and offer; insured patients may pay $0–$25/month |
| Made by | USA, FDA-registered, GMP facility | Novo Nordisk (pharmaceutical) |
Body's own GLP-1 & GIP pathways · Gummy
ProsPharmaceutical GLP-1 receptor agonist (semaglutide) · Once-weekly injection pen (oral pill version also exists)
ProsJellyLean sits in the category of natural products designed to support the body's own GLP-1 response: acetic acid and botanicals that can slow stomach emptying, prolong fullness, and nudge the GLP-1/GIP satiety signals — real but modest biology. Wegovy (semaglutide) is an FDA-approved prescription GLP-1 receptor agonist injection from Novo Nordisk, indicated for chronic weight management in adults with obesity or overweight with a weight-related condition, alongside diet and exercise. It is a medication — not a supplement — with clinically demonstrated weight loss, prescription-only access, and pharmaceutical pricing: list price is $1,349.02 per package, with NovoCare® self-pay options from $199–$349 per month depending on dose and current offers, and insured patients potentially paying $0–$25 per month.
Important: no supplement, gummy, or botanical replicates prescription GLP-1 medication. Supplement benefits are supportive and gradual, alongside a balanced diet and activity. Results vary by individual.
JellyLean starts from $49 per bottle with multi-bottle bundles, a 60-day money-back guarantee, and U.S. shipping. Wegovy: List price $1,349.02/package; NovoCare self-pay from $199–$349/month depending on dose and offer; insured patients may pay $0–$25/month. As a prescription medication it carries no money-back guarantee, and ongoing monthly cost continues for as long as treatment does.
This comparison is written for shoppers in the United States (pricing in USD). JellyLean ships within the U.S. from its official website; orders typically process in 2–3 days with delivery in roughly 5–7 business days. Wegovy availability: prescription only — pharmacy or novocare® pharmacy home delivery.
These products are in different categories, and pretending otherwise would mislead you. If you meet the medical criteria, can access a prescription, and the cost works for you, Wegovy delivers clinically proven weight loss that no supplement — JellyLean included — can match. JellyLean is the over-the-counter route: a $49 natural gummy that supports the body’s own GLP-1 and GIP pathways for gradual, supplement-level results, with no prescription, no injections, and a 60-day money-back guarantee. Choose based on your eligibility, budget, and how you weigh medication side effects against modest natural support.
No. Wegovy is an FDA-approved prescription medication with clinically demonstrated weight loss. JellyLean is a dietary supplement that supports the body’s own GLP-1 and GIP pathways; its effects are gradual and supplement-level. Never stop or substitute a prescribed medication without talking to your doctor.
JellyLean starts at $49 per bottle (about a month’s supply). Wegovy’s list price is $1,349.02 per package; cash-pay programs run roughly $199–$349+ per month, while well-insured patients may pay $0–$25 per month. Over a year, the self-pay gap can exceed several thousand dollars.
Wegovy is indicated for adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition, and for some adolescents — determined by a licensed prescriber. JellyLean, as a supplement, requires no prescription.
Wegovy’s most common side effects include nausea, vomiting, diarrhea, and constipation, and it carries a boxed warning regarding thyroid C-cell tumors observed in rodents. JellyLean is a stimulant-free natural gummy generally well tolerated, though anyone on medication or with a health condition should consult a doctor first.